Esomeprazole for preventing radiation-induced esophagitis
Treatments studied
Part of Digestive system, Lungs & breathing clinical trials.
This study tests whether a common heartburn medicine (esomeprazole) can help prevent or reduce painful swallowing caused by radiation for lung cancer. If you have stage 3 non-small cell lung cancer and are getting chemo and chest radiation, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have stage 3 non-small cell lung cancer.
- You are scheduled to get both chemotherapy and radiation to your chest.
- You do not have severe swallowing problems now.
- You have not had radiation to your chest in the last 2 years.
- You are not taking certain other medicines (like clopidogrel, methotrexate, or digoxin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a daily acid-reducing medication (a PPI, like omeprazole) during radiation for lung cancer can protect your food pipe (esophagus) from irritation. The goal is to reduce discomfort like pain or difficulty swallowing caused by radiation.
This Phase 3 trial tests whether giving preventive (prophylactic) radiation reduces cancer coming back in people with early esophagus cancer after standard chemoradiation. It may help by lowering the chance that microscopic cancer spreads to nearby areas.
This trial studies whether proton therapy can better treat early-to-mid stage esophagus cancer while aiming to reduce side effects to nearby organs. Proton therapy uses a targeted type of radiation, and participants are also checked to be eligible for curative surgery.
This trial tests if a special nutritional supplement (immunonutrition) can lower the risk of severe throat and chest irritation (esophagitis) caused by radiation therapy for lung cancer. You may qualify if you are about to start chest radiation and can eat normally.
This study tests a new pre-surgery treatment plan that combines chemotherapy with focused, shorter-course radiation for esophagus or stomach-where-it-meets-the-esophagus (GEJ) adenocarcinoma. The goal is to shrink the tumor before surgery and improve treatment outcomes.
This study looks at whether giving radiation after surgery (after chemo and radiation before surgery) can improve outcomes for people with squamous cell esophagus cancer in the chest. You may be considered if you are well enough for treatment and your cancer has not spread.
Hear when a new Locally Advanced Lung Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.